In Vitro Activity of Sulbactam–Durlobactam against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Multicentre Report from Italy

In the present study, the in vitro activity of the sulbactam–durlobactam (SUL–DUR) combination was evaluated against 141 carbapenem-resistant A. baumannii (CRAb) clinical strains collected from six Italian laboratories. Over half (54.6%) of these isolates were resistant to colistin. The SUL–DUR comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Segatore, Bernardetta, Piccirilli, Alessandra, Cherubini, Sabrina, Principe, Luigi, Alloggia, Giovanni, Mezzatesta, Maria Lina, Salmeri, Mario, Di Bella, Stefano, Migliavacca, Roberta, Piazza, Aurora, Meroni, Elisa, Fazii, Paolo, Visaggio, Daniela, Visca, Paolo, Cortazzo, Venere, De Angelis, Giulia, Pompilio, Arianna, Perilli, Mariagrazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404735/
https://www.ncbi.nlm.nih.gov/pubmed/36010006
http://dx.doi.org/10.3390/antibiotics11081136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404735/
https://www.ncbi.nlm.nih.gov/pubmed/36010006
http://dx.doi.org/10.3390/antibiotics11081136

Ejemplares similares